SEC-sourced researchBeta
OM
Outset Medical, Inc.
Company comparison ↗
Data passport
- CIK
- 0001484612
- Exchange
- Nasdaq
- Business activity
- — · SIC 3845
- Financial inputs
- 6/6
- Filing date
- Oct 6, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2023 | 130,376,000.0000 | Feb 13, 2026 |
| December 2024 | 113,689,000.0000 | Feb 13, 2026 |
| December 2025 | 119,476,000.0000 | Feb 13, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 119,476,000.0000 | -81,653,000.0000 | -46,327,000.0000 | 264,496,000.0000 | 137,544,000.0000 | Feb 13, 2026 |
| December 2024 | 113,689,000.0000 | -127,976,000.0000 | -116,303,000.0000 | 275,795,000.0000 | 248,976,000.0000 | Feb 13, 2026 |
| December 2023 | 130,376,000.0000 | -172,797,000.0000 | -131,373,000.0000 | — | — | Feb 13, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $119.48M | December 2025 | Feb 13, 2026 | 10-K |
| Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax | $113.69M | December 2024 | Feb 13, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$81.65M | December 2025 | Feb 13, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$46.33M | December 2025 | Feb 13, 2026 | 10-K |
| Total assetsAssets | $264.5M | December 2025 | Feb 13, 2026 | 10-K |
| Total liabilitiesLiabilities | $137.54M | December 2025 | Feb 13, 2026 | 10-K |